These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Disease spectrum of intraductal papillary mucinous neoplasm with an associated invasive carcinoma invasive IPMN versus pancreatic ductal adenocarcinoma-associated IPMN. Kang MJ, Lee KB, Jang JY, Kwon W, Park JW, Chang YR, Kim SW. Pancreas; 2013 Nov; 42(8):1267-74. PubMed ID: 24308063 [Abstract] [Full Text] [Related]
8. Magnetic resonance imaging short protocols for intraductal papillary mucinous neoplasm (IPMN) surveillance: The time has come. D'Onofrio M, Geraci L, De Robertis RL, Cardobi N, Balduzzi A, Tomaiuolo L, Bardhi E, Faccioli N, Aluffi G, Marchegiani G, Salvia R. Dig Liver Dis; 2024 Sep; 56(9):1551-1556. PubMed ID: 38614923 [Abstract] [Full Text] [Related]
15. Uncinate duct dilation in intraductal papillary mucinous neoplasms of the pancreas: a radiographic finding with potentially increased malignant potential. Ammori JB, Do RK, Brennan MF, D'Angelica MI, Dematteo RP, Fong Y, Jarnagin WR, Allen PJ. J Gastrointest Surg; 2014 May; 18(5):911-6. PubMed ID: 24448998 [Abstract] [Full Text] [Related]
16. Magnetic resonance (MR) for mural nodule detection studying Intraductal papillary mucinous neoplasms (IPMN) of pancreas: Imaging-pathologic correlation. D'Onofrio M, Tedesco G, Cardobi N, De Robertis R, Sarno A, Capelli P, Martini PT, Giannotti G, Beleù A, Marchegiani G, Gobbo S, Butturini G, Bogdan M, Salvia R, Bassi C. Pancreatology; 2021 Jan; 21(1):180-187. PubMed ID: 33376061 [Abstract] [Full Text] [Related]
17. Evaluation of SOX9 expression in pancreatic ductal adenocarcinoma and intraductal papillary mucinous neoplasm. Tanaka T, Kuroki T, Adachi T, Ono S, Hirabaru M, Soyama A, Kitasato A, Takatsuki M, Hayashi T, Eguchi S. Pancreas; 2013 Apr; 42(3):488-93. PubMed ID: 23146920 [Abstract] [Full Text] [Related]
18. Diffusion-weighted magnetic resonance imaging for evaluating the histological degree of malignancy in patients with intraductal papillary mucinous neoplasm. Ogawa T, Horaguchi J, Fujita N, Noda Y, Kobayashi G, Ito K, Koshita S, Kanno Y, Masu K, Sugita R. J Hepatobiliary Pancreat Sci; 2014 Nov; 21(11):801-8. PubMed ID: 25082473 [Abstract] [Full Text] [Related]
19. Concomitant Intraductal Papillary Mucinous Neoplasm in Pancreatic Ductal Adenocarcinoma Is an Independent Predictive Factor for the Occurrence of New Cancer in the Remnant Pancreas. Matsuda R, Miyasaka Y, Ohishi Y, Yamamoto T, Saeki K, Mochidome N, Abe A, Ozono K, Shindo K, Ohtsuka T, Kikutake C, Nakamura M, Oda Y. Ann Surg; 2020 May; 271(5):941-948. PubMed ID: 30308608 [Abstract] [Full Text] [Related]